REFERENCES
- Schiantarelli H., Cadel S. Piroxicam pharmacologic activity and gastrointestinal damage by oral and rectal route. Arzneim.-Forsch. (Drug Res.) 1981; 31: 87–92
- Schiantarelli P., Cadel S., Acerbi D., Pavesi L. Anti-inflammatory activity and bioavailability of percutaneous piroxicam. Arzneim.-Forch. (Drug Res.) 1982; 32: 230–235
- Chien Y. W. Logics of transdermal controlled drug administration. Drug Dev. Ind. Pharm. 1983; 9: 497–520
- Chien Y. W., Valia K. H. Development of a dynamic skin permeation system for long-term permeation studies. Drug Dev. Ind. Pharm. 1984; 10: 575–599
- Schmolka I. R. Artificial skin I. Preparation and properties of pluronic F-127 gels for the treatment of burns. J. Biomed. Mater. Res. 1972; 6: 571–582
- Higuchi T. Physicochemical analysis of percutaneous absorption process from creams and ointments. J. Soc. Cosmet. Chem. 1960; 11: 85–97
- Al-Saden A. A., Florence A. T., Morrison H., Whateley T. L. Association of poloxamer block copoly- mers in aqueous solution. J. Pharm. Pharmacol. 1979; 31: 81
- Attwood D., Collett J. H., Tai C. J. The micellar properties of the poly(oxyethylene) poly(oxypropylene) copolymer pluronic F 127 in water and electrolyte solution. Int. J. Pharm. 1985; 26: 25–33
- Collett J. H., Tait C. J., Attwood H. L., Sharma H. L., Smith A. M. In vitro evaluation of poloxamer gels as controlled release systems using r-scintigraphy. Proc. Int. Symp. Controlled Release Bioact. Mater. 1985; 12: 28–29
- Hsueh-Ling S. W., Susan C. M. In vitro release of nicotinic acid alkyl esters from poloxamer vehicles. Int. J. Pharm. 1990; 66: 213–221
- Miyazaki S., Yokouchi C., Nakamura T., Hashiguchi N., Hou W. M., Takada M. Pluronic F-127 gels as a novel vehicle for rectal administration of indomethacin. Chem. Pharm. Bull. 1986; 34: 1801–1808
- Flynn G. L., Yalkowsky S. H., Roseman T. J. Mass transport phenomena and models: theoretical concepts. J. Pharm. Sci. 1974; 63: 479–510